Introduction
Nuclides of indium have found widespread use in nuclear medicine. ln, a /-emitting isotope, has nearly ideal physical characteristics (it decays by electron capture emitting 2 usable gamma photons of 173 KeV and 247 KeV with a 184% photon yield [1] ). ln has a half-life of 2.8 days which allows studies over several days with small activities administered radioactivity [2] . It also presents suitable chemical properties for in vivo applications: only the 3+ oxidation state occurs in water and its aqueous chemistry is dominated by its strong Lewis acidity and oxophilicity [3] .
Among the chelating agents which have found applications in medicine, DTPA (diethylenetriaminepentaacetic acid) remains one of the most used [2] , because it forms stable complexes with many cations and allows the preparation of bifunctional chelating derivatives; it can easily be linked to high molecular weight compounds. 4In(DTPA) has been described as an ideal agent for scintigraphic studies of the cerebrospinal fluid pathway [4, 5] .
Functionalization may be important to increase the selectivity of a radiotracer and to modulate its hydrophilic/lipophilic character. Since the biodistribution and excretion of substances injected into the blood stream are influenced by factors like molecular size, molecular weight, charge and hydrophilicity of the complex [6] , we study in this work the in vitro and in vivo behaviour of ln complexes of the DTPA analogue TTHA (triethylenetetraaminehexaacetic acid) and of two of its derivatives, TTHA-bis(butylamide) and TTHA-bis(glucamide) (Fig.l) In(DTPA) [12] [7, 14] . 3.2. Images and biodistribution data Fig.2 represents the averaged time-activity curves, obtained from the dynamic acquisitions for each region of interest. The curves were smoothed and normalised for the maximum activity of each one. The complexes studied undergo an early retention, both in kidneys and in liver and spleen. These results contrast with the time-activity curves obtained for the In(DTPA) complex, where the liver-spleen curve is similar to the thorax curve, corresponding to blood activity. The thorax curves for the In(TTHA) , In(TTHABuA)-and In(TTHAGluA) chelates also correspond only to blood activity.
The scintigraphic images at 30 minutes, 24 h and 72 h after ln chelates injection in rats are illustrated in Fig.3 . In the early images, and for all the complexes, the activity is preferentially Iocalised in kidneys. In some of these images the injection site is also observed. After 24 h the activity was spread out and was then Iocalised mainly in the abdominal region and in the kidneys. The 72 h images show the same behaviour, but it is particularly noticeable that In(TTHAGluA) has higher uptake by the liver-spleen region. The high late retention of the 111n complexes of TTHA, TTHABuA2 and TTHAGluA2 by the reticulo-endothelial system may be related with the formation of colloidal particles of indium hydroxide associated with partial demetallation of the chelates [15] , in addition to the natural occurrence of the complexes. High radioactivity levels in blood after 30 minutes suggest that the complexes may bind to serum proteins, perhaps albumin, but further in vitro studies are necessary to validate this hypothesis. None of the complexes passes through the blood-brain barrier, as expected for high molecular weight and non-lipophilic complexes. There is no evidence of bone marrow accumulation, which is seen when the indium-transferrin complex is formed [16] .
In conclusion TTHA and its derivatives have similar in vivo behaviour and the linkage of the lipophilic side chains in the case of TTHABuA2 and TTHAGluA2 does not seem to influence the biodistribution and clearance of these complexes.
